Reteplase biosimilar（Healthgen）
瑞替普酶生物类似药（禾元生物）
Report date: 2025/07/29 13:45:27
Base Information
Drug NameReteplase biosimilar（Healthgen）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Healthgen Biotechnology Corp
China Registration ClassN/A
Develop Information
Active CompaniesWuhan Healthgen Biotechnology Corp
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A